Clinical Trial Site

Richmond, Virginia 23298

4 studies enrolling now · 8 studies all time

What they study most

Advanced Hepatocellular Carcinoma, Amyloid Neuropathies, Amyloid Neuropathies, Familial, Amyloidosis, Hereditary, Amyloidosis, Hereditary, Transthyretin-Related, Familial Amyloidotic Cardiomyopathy (FAC), Familial Transthyretin Cardiac Amyloidosis, Hearing Loss, Sensorineural, High Cardiovascular Risk, High Risk Cardiovascular Disease, Hypertension, Lichen Planopilaris

Studies at this site

• TRITON-CM: A Study to Evaluate Nucresiran in Patients With Transthyretin Amyloidosis With Cardiomyopathy — Recruiting now
• Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease — Recruiting now
• A Phase 2/3 Study of Brepocitinib in Adults With Lichen Planopilaris — Recruiting now
• A Study to Evaluate ALN-BCAT in Patients With Hepatocellular Carcinoma — Recruiting now
• FX-322 in Adults With Stable Sensorineural Hearing Loss — Completed
• FX-322 in Adults With Acquired Sensorineural Hearing Loss — Completed
• ENDEAVOUR: Phase 3 Multicenter Study of Revusiran (ALN-TTRSC) in Patients With Transthyretin (TTR) Mediated Familial Amyloidotic Cardiomyopathy (FAC) — Completed
• DISCOVERY: A Study Examining the Prevalence of TTR Mutations in Subjects Suspected of Having Cardiac Amyloidosis — Completed